Pancreatic Cancer Research

ResearcherHuazhong University of Science and TechnologyActive in the last 2 years

Beibei Zhu

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2014: 3 papers · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 8

  1. Author Correction: Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations. Co-author DOI 10.1038/s41467-025-58613-9↗
  2. Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations. Co-author DOI 10.1038/s41467-018-06136-x↗
  3. A single nucleotide polymorphism in the 3'-UTR of STAT3 regulates its expression and reduces risk of pancreatic cancer in a Chinese population. Co-author DOI 10.18632/oncotarget.11607↗
  4. Genetic variants in the SWI/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population. Co-author DOI 10.1002/mc.22140↗
  5. SF3A1 and pancreatic cancer: new evidence for the association of the spliceosome and cancer. Co-author DOI 10.18632/oncotarget.5647↗
  6. Non-linear dose-response relationship between cigarette smoking and pancreatic cancer risk: evidence from a meta-analysis of 42 observational studies. Co-author DOI 10.1016/j.ejca.2013.08.014↗
  7. Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies. Co-author DOI 10.1038/srep05313↗
  8. [Association between pancreatic cancer risk and the interaction of U2AF65 gene polymorphisms and smoking]. First author PMID 25174478↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rong Zhong · 8 shared papers, 2014–2025 · strength 0.50
  2. Xiaoping Miao · 8 shared papers, 2014–2025 · strength 0.50
  3. Juntao Ke · 5 shared papers, 2014–2025 · strength 0.36
  4. Ying Zhu · 3 shared papers, 2016–2025 · strength 0.29
  5. Jianbo Tian · 3 shared papers, 2016–2025 · strength 0.29
  6. Jiang Chang · 3 shared papers, 2016–2025 · strength 0.29
  7. Kun Huang · 2 shared papers, 2018–2025 · strength 0.24
  8. Ming Yang · 2 shared papers, 2018–2025 · strength 0.24
  9. Li Wang · 2 shared papers, 2018–2025 · strength 0.24
  10. Chen Hsuan Wu · 2 shared papers, 2018–2025 · strength 0.24
  11. Dongxin Lin · 2 shared papers, 2018–2025 · strength 0.24
  12. Li Zou · 4 shared papers, 2014–2015 · strength 0.16
  13. Jing Tian · 3 shared papers, 2014–2015 · strength 0.13
  14. Yao Tian · 3 shared papers, 2014–2015 · strength 0.13
  15. Li Wang · 2 shared papers, 2014–2015 · strength 0.09
  16. Wei Chen · 2 shared papers, 2014 · strength 0.08
  17. Li Liu · 1 shared paper, 2015 · strength 0.04
  18. Li Liu · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.